Fred Hutch study paves the way for potential muscular dystrophy treatment A new study conducted at the Fred Hutchinson Cancer Research Center in Seattle has found a new potential target for… Read More
UW biotech spinout DMD Therapeutics raises $400k to pursue treatment for rare form of muscular dystrophy DMD Therapeutics, a biotech startup that was spun out of the University of Washington by biotech entrepreneur Ron Berenson last year, is… Read More
